These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38465197)

  • 21. Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy.
    Singh T; Kim TW; Murthy ASN; Paul M; Sepay N; Jeong Kong H; Sung Ryu J; Rim Koo N; Yoon S; Song KH; Jun Baek M; Jeon S; Im J
    Eur J Med Chem; 2024 Feb; 265():116050. PubMed ID: 38128233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy.
    Cho HJ; Park SJ; Lee YS; Kim S
    J Control Release; 2019 Apr; 300():73-80. PubMed ID: 30831135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
    Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery.
    Kang S; Lee S; Park S
    Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study.
    Zuo HD; Yao WW; Chen TW; Zhu J; Zhang JJ; Pu Y; Liu G; Zhang XM
    Biomed Res Int; 2014; 2014():852352. PubMed ID: 24977163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
    Chu Y; Chen N; Yu H; Mu H; He B; Hua H; Wang A; Sun K
    Int J Nanomedicine; 2017; 12():1353-1368. PubMed ID: 28260884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.
    Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D
    Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma.
    Li H; Shi S; Wu M; Shen W; Ren J; Mei Z; Ran H; Wang Z; Tian Y; Gao J; Zhao H
    Int J Nanomedicine; 2021; 16():6455-6475. PubMed ID: 34584411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-mediated delivery of therapeutic RNA by peptide functionalized curdlan nanoparticles.
    Ganbold T; Han S; Hasi A; Baigude H
    Int J Biol Macromol; 2019 Apr; 126():633-640. PubMed ID: 30572048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.
    Mao X; Liu J; Gong Z; Zhang H; Lu Y; Zou H; Yu Y; Chen Y; Sun Z; Li W; Li B; Gao J; Zhong Y
    Nanomedicine (Lond); 2015; 10(17):2677-95. PubMed ID: 26355733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-administration of biocompatible self-assembled polylactic acid-hyaluronic acid block copolymer nanoparticles with tumor-penetrating peptide-iRGD for metastatic breast cancer therapy.
    Deng C; Xu X; Tashi D; Wu Y; Su B; Zhang Q
    J Mater Chem B; 2018 May; 6(19):3163-3180. PubMed ID: 32254351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Specific Drug Delivery System for Targeted Accumulation and Tissue Penetration in Prostate Tumors Based on Microbially Synthesized PHBHHx Biopolyester and iRGD Peptide Fused PhaP.
    Fan F; Wu X; Zhao J; Ran G; Shang S; Li M; Lu X
    ACS Appl Bio Mater; 2018 Dec; 1(6):2041-2053. PubMed ID: 34996266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. iRGD-Mediated and Enzyme-Induced Precise Targeting and Retention of Gold Nanoparticles for the Enhanced Imaging and Treatment of Breast Cancer.
    Yang Y; Chen Q; Li S; Ma W; Yao G; Ren F; Cai Z; Zhao P; Liao G; Xiong J; Yu Z
    J Biomed Nanotechnol; 2018 Aug; 14(8):1396-1408. PubMed ID: 29903055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. iRGD-decorated reduction-responsive nanoclusters for targeted drug delivery.
    Hu H; Wan J; Huang X; Tang Y; Xiao C; Xu H; Yang X; Li Z
    Nanoscale; 2018 Jun; 10(22):10514-10527. PubMed ID: 29799599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
    Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-penetrating delivery of compounds and nanoparticles into tumors.
    Sugahara KN; Teesalu T; Karmali PP; Kotamraju VR; Agemy L; Girard OM; Hanahan D; Mattrey RF; Ruoslahti E
    Cancer Cell; 2009 Dec; 16(6):510-20. PubMed ID: 19962669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-targeting exosomes for improved drug delivery in breast cancer.
    Tran NH; Nguyen DD; Nguyen NM; Tran C; Nguyen Thi NT; Ho DT; Nguyen HN; Tu LN
    Nanomedicine (Lond); 2023 Mar; 18(7):599-611. PubMed ID: 37194929
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting.
    Lingasamy P; Laarmann AH; Teesalu T
    Curr Cancer Drug Targets; 2021; 21(1):70-79. PubMed ID: 33001014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.